Gujarat Themis Biosyn Ltd vs Makers Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 363.75 as of 30 Apr 15:30 . The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Makers Laboratories Ltd changed from 18 on March 2022 to 10.2 on March 2025 . This represents a CAGR of -13.24% over 4 years The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Makers Laboratories Ltd changed from ₹ 117.71 crore on March 2021 to ₹ 76.11 crore on March 2025 . This represents a CAGR of -8.35% over 5 years The revenue of Gujarat Themis Biosyn Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Makers Laboratories Ltd for the Dec '25 is ₹ 35.99 crore as compare to the Sep '25 revenue of ₹ 34.53 crore. This represent the growth of 4.23% The ebitda of Gujarat Themis Biosyn Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Makers Laboratories Ltd for the Dec '25 is ₹ 4.49 crore as compare to the Sep '25 ebitda of ₹ 2.64 crore. This represent the growth of 70.08% The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Makers Laboratories Ltd changed from ₹ -0.7 crore to ₹ 2.27 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 36.62 % on March 2022 to 14.97 % on March 2025 . This represents a CAGR of -20.04% over 4 yearsThe Dividend Payout of Makers Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Gujarat Themis Biosyn Ltd

Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

About Makers Laboratories Ltd

Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984.
The Company was promoted by Satish Kumar Gupta and Naval Tated.
The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993.
As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit.

FAQs for the comparison of Gujarat Themis Biosyn Ltd and Makers Laboratories Ltd

Which company has a larger market capitalization, Gujarat Themis Biosyn Ltd or Makers Laboratories Ltd?

Market cap of Gujarat Themis Biosyn Ltd is 3,963 Cr while Market cap of Makers Laboratories Ltd is 83 Cr

What are the key factors driving the stock performance of Gujarat Themis Biosyn Ltd and Makers Laboratories Ltd?

The stock performance of Gujarat Themis Biosyn Ltd and Makers Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Themis Biosyn Ltd and Makers Laboratories Ltd?

As of May 3, 2026, the Gujarat Themis Biosyn Ltd stock price is INR ₹363.75. On the other hand, Makers Laboratories Ltd stock price is INR ₹141.05.

How do dividend payouts of Gujarat Themis Biosyn Ltd and Makers Laboratories Ltd compare?

To compare the dividend payouts of Gujarat Themis Biosyn Ltd and Makers Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.